Skip to main content
Elena Perez, MD, Allergy & Immunology, Juno Beach, FL

ElenaEPerezMD

Allergy & Immunology Juno Beach, FL

Partner, Allergy Associates of the Palm Beaches

Dr. Perez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Perez's full profile

Already have an account?

  • Office

    840 US Highway 1
    Ste 243
    Juno Beach, FL 33408
    Phone+1 561-626-2006
    Fax+1 561-626-8622

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Allergy and Immunology, 2001 - 2004
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 1998 - 2001
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2009 - 2025
  • PA State Medical License
    PA State Medical License 1999 - 2008
  • American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Publications & Presentations

PubMed

Press Mentions

  • Kedrion Biopharma Announces First Patient Enrolled in CARES10, a Phase 3, Multi-Center Study to Assess a 10 Percent Intravenous Immunoglobulin in Adults with Primary Immunodeficiency Disease
    Kedrion Biopharma Announces First Patient Enrolled in CARES10, a Phase 3, Multi-Center Study to Assess a 10 Percent Intravenous Immunoglobulin in Adults with Primary Immunodeficiency DiseaseAugust 12th, 2019
  • GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-Stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
    GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-Stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)December 19th, 2023

Grant Support

  • Uncovering Co-Stimulatory T Cell Help Defects In Common Variable ImmunodeficiencyNational Institute Of Allergy And Infectious Diseases2009–2010
  • Engineering Primary T Cells For Resistance To HIV-1National Institute Of Allergy And Infectious Diseases2008
  • Engineering Primary T Cells For Resistance To HIV-1National Institute Of Allergy And Infectious Diseases2004–2008
  • Minority Predoctoral Fellowship Program--NigmsNational Institute Of General Medical Sciences1994–1996
  • Minority Predoctoral Fellowship Program - NigmsNational Institute Of General Medical Sciences1991–1993

Committees

  • Chairperson (former), Primary Immune Deficiency Committee AAAAI
  • Chairperson (former), Basic and Clinical Immunology Interest Section AAAAI

Professional Memberships

Other Languages

  • Spanish